Accès à distance ? S'identifier sur le proxy UCLouvain
Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Publication date | 2013 |
Language | Anglais |
Journal information | "Pharmacogenetics and Genomics" - Vol. 23, no.3, p. 148-155 (2013) |
Peer reviewed | yes |
Publisher | Lippincott Williams & Wilkins ((United States) Philadelphia, PA) |
issn | 1744-6872 |
e-issn | 1744-6880 |
Publication status | Publié |
Affiliations |
UCL
- SSS/LDRI - Louvain Drug Research Institute UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology UCL - (SLuc) Service de biochimie médicale |
MESH Subject | Cytochrome P-450 CYP3A ; Erythromycin ; Female ; Humans ; Male ; Midazolam ; Phenotype |
Links |
Bibliographic reference | Elens, Laure ; Nieuweboer, Annemieke J M ; Clarke, Stephen J ; Charles, Kellie A ; de Graan, Anne-Joy M ; et. al. Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin.. In: Pharmacogenetics and Genomics, Vol. 23, no.3, p. 148-155 (2013) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/146515 |